CRISPR Therapeutics AG (CRSP) Other Working Capital Changes (2017 - 2026)
CRISPR Therapeutics AG (CRSP) posted Other Working Capital Changes of -$427000.0 for Q1 2026, down 119.83% sequentially from $2.2 million in Q4 2025, and up 48.18% YoY from -$288163.8 in Q1 2025.
CRISPR Therapeutics AG (CRSP) Other Working Capital Changes (2017 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported Other Working Capital Changes for 10 years, with the latest figure at -$427000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 48.18% year-over-year to -$427000.0 in Q1 2026, while the trailing twelve-month figure through Dec 2025 was -$397000.0 (up 79.63% YoY) and the FY2025 annual result came in at -$397000.0, up 79.63% from the prior year.
- Other Working Capital Changes fell to -$427000.0 in Q1 2026 per CRSP's latest filing, from $2.2 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $5.5 million in Q4 2022 and troughed at -$12.0 million in Q1 2023.
- A 5-year average of -$2.0 million and a median of -$817000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes slumped 6125.0% in 2022, then jumped 2711.24% in 2023.
- Over 5 years, Other Working Capital Changes stood at -$249000.0 in 2022, then tumbled by 384.34% to -$1.2 million in 2023, then jumped by 47.1% to -$638000.0 in 2024, then jumped by 437.46% to $2.2 million in 2025, then plunged by 119.83% to -$427000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$427000.0, $2.2 million, and -$834000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -155,000.00 |
| Jun 30, 2026 | -155,000.00 |
| Jun 30, 2026 | -155,000.00 |
| Mar 31, 2026 | -427,000.00 |
| Mar 31, 2026 | -427,000.00 |
| Mar 31, 2026 | -427,000.00 |
| Dec 31, 2025 | 2.15 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | -834,000.00 |
| Sep 30, 2025 | -834,000.00 |
| Sep 30, 2025 | -834,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Mar 31, 2025 | -824,000.00 |
| Mar 31, 2025 | -824,000.00 |
| Mar 31, 2025 | -824,000.00 |
| Dec 31, 2024 | -638,000.00 |
| Dec 31, 2024 | -638,000.00 |